Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy

被引:326
作者
Nair, Dileep R. [1 ]
Laxer, Kenneth D. [2 ]
Weber, Peter B. [2 ]
Murro, Anthony M. [3 ]
Park, Yong D. [3 ]
Barkley, Gregory L. [4 ]
Smith, Brien J. [5 ]
Gwinn, Ryder P. [6 ]
Doherty, Michael J. [6 ]
Noe, Katherine H. [7 ]
Zimmerman, Richard S. [7 ]
Bergey, Gregory K. [8 ]
Anderson, William S. [8 ]
Heck, Christianne [9 ]
Liu, Charles Y. [9 ]
Lee, Ricky W. [10 ]
Sadler, Toni [10 ]
Duckrow, Robert B. [11 ]
Hirsch, Lawrence J. [11 ]
Wharen, Robert E., Jr. [12 ]
Tatum, William [12 ]
Srinivasan, Shraddha [13 ]
McKhann, Guy M. [13 ]
Agostini, Mark A. [14 ]
Alexopoulos, Andreas V. [1 ]
Jobst, Barbara C. [15 ]
Roberts, David W. [15 ]
Salanova, Vicenta [16 ]
Witt, Thomas C. [16 ]
Cash, Sydney S. [17 ]
Cole, Andrew J. [17 ]
Worrell, Gregory A. [18 ]
Lundstrom, Brian N. [18 ]
Edwards, Jonathan C. [19 ]
Halford, Jonathan J. [19 ]
Spencer, David C. [20 ]
Ernst, Lia [20 ]
Skidmore, Christopher T. [21 ]
Sperling, Michael R. [21 ]
Miller, Ian [22 ]
Geller, Eric B. [23 ]
Berg, Michel J. [24 ]
Fessler, A. James [24 ]
Rutecki, Paul [25 ]
Goldman, Alica M. [26 ]
Mizrahi, Eli M. [26 ]
Gross, Robert E. [27 ]
Shields, Donald C. [28 ]
Schwartz, Theodore H. [29 ]
Labar, Douglas R. [29 ]
机构
[1] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Calif Pacific Med Ctr, San Francisco, CA USA
[3] Augusta Univ, Augusta, GA USA
[4] Henry Ford Hosp, Detroit, MI 48202 USA
[5] Ohio Hlth Neurosci, Columbus, OH USA
[6] Swedish Neurosci Inst, Seattle, WA USA
[7] Mayo Clin Arizona, Scottsdale, AZ USA
[8] Johns Hopkins Med, Baltimore, MD USA
[9] USC, Keck Sch Med, Los Angeles, CA USA
[10] Via Christi Epilepsy Ctr, Wichita, KS USA
[11] Yale Univ, Sch Med, New Haven, CT USA
[12] Mayo Clin Florida, Jacksonville, FL USA
[13] Columbia Univ, Med Ctr, New York, NY USA
[14] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[15] Geisel Sch Med Dartmouth, Hanover, NH USA
[16] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[17] Massachusetts Gen Hosp, Boston, MA 02114 USA
[18] Mayo Clin Minnesota, Rochester, MN USA
[19] Med Univ South Carolina, Charleston, SC 29425 USA
[20] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[21] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[22] Nicklaus Childrens Hosp, Miami, FL USA
[23] St Barnabas Hosp, Livingston, NJ USA
[24] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[25] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
[26] Baylor Coll Med, Houston, TX 77030 USA
[27] Emory Univ, Sch Med, Atlanta, GA USA
[28] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[29] Weill Cornell Med Coll, New York, NY USA
[30] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[31] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
[32] Univ Florida, Gainesville, FL USA
[33] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[34] NeuroPace Inc, Mountain View, CA 94043 USA
[35] Stanford Univ, Palo Alto, CA 94304 USA
关键词
SUDDEN UNEXPECTED DEATH; QUALITY-OF-LIFE; LOCALIZED NEOCORTICAL RESECTIONS; VAGUS NERVE-STIMULATION; TEMPORAL-LOBE; LONG-TERM; STANDARDS-SUBCOMMITTEE; CORTICAL STIMULATION; PRACTICE PARAMETER; SURGERY;
D O I
10.1212/WNL.0000000000010154
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To prospectively evaluate safety and efficacy of brain-responsive neurostimulation in adults with medically intractable focal onset seizures (FOS) over 9 years. Methods Adults treated with brain-responsive neurostimulation in 2-year feasibility or randomized controlled trials were enrolled in a long-term prospective open label trial (LTT) to assess safety, efficacy, and quality of life (QOL) over an additional 7 years. Safety was assessed as adverse events (AEs), efficacy as median percent change in seizure frequency and responder rate, and QOL with the Quality of Life in Epilepsy (QOLIE-89) inventory. Results Of 256 patients treated in the initial trials, 230 participated in the LTT. At 9 years, the median percent reduction in seizure frequency was 75% (p < 0.0001, Wilcoxon signed rank), responder rate was 73%, and 35% had a >= 90% reduction in seizure frequency. We found that 18.4% (47 of 256) experienced >= 1 year of seizure freedom, with 62% (29 of 47) seizure-free at the last follow-up and an average seizure-free period of 3.2 years (range 1.04-9.6 years). Overall QOL and epilepsy-targeted and cognitive domains of QOLIE-89 remained significantly improved (p < 0.05). There were no serious AEs related to stimulation, and the sudden unexplained death in epilepsy (SUDEP) rate was significantly lower than predefined comparators (p < 0.05, 1-tailed chi(2)). Conclusions Adjunctive brain-responsive neurostimulation provides significant and sustained reductions in the frequency of FOS with improved QOL. Stimulation was well tolerated; implantation-related AEs were typical of other neurostimulation devices; and SUDEP rates were low. ClinicalTrials.gov identifier NCT00572195. Classification of evidence This study provides Class IV evidence that brain-responsive neurostimulation significantly reduces focal seizures with acceptable safety over 9 years.
引用
收藏
页码:E1244 / E1256
页数:13
相关论文
共 45 条
[1]  
[Anonymous], 2018, RNS SYSTEM USER MANU
[2]   Gauging seizure risk [J].
Baud, Maxime O. ;
Rao, Vikram R. .
NEUROLOGY, 2018, 91 (21) :967-973
[3]   Multi-day rhythms modulate seizure risk in epilepsy [J].
Baud, Maxime O. ;
Kleen, Jonathan K. ;
Mirro, Emily A. ;
Andrechak, Jason C. ;
King-Stephens, David ;
Chang, Edward F. ;
Rao, Vikram R. .
NATURE COMMUNICATIONS, 2018, 9
[4]   Surgical and neurological complications in a series of 708 epilepsy surgery procedures [J].
Behrens, E ;
Schramm, J ;
Zentner, J ;
Konig, R .
NEUROSURGERY, 1997, 41 (01) :1-9
[5]   Long-term treatment with responsive brain stimulation in adults with refractory partial seizures [J].
Bergey, Gregory K. ;
Morrell, Martha J. ;
Mizrahi, Eli M. ;
Goldman, Alica ;
King-Stephens, David ;
Nair, Dileep ;
Srinivasan, Shraddha ;
Jobst, Barbara ;
Gross, Robert E. ;
Shields, Donald C. ;
Barkley, Gregory ;
Salanova, Vicenta ;
Olejniczak, Piotr ;
Cole, Andrew ;
Cash, Sydney S. ;
Noe, Katherine ;
Wharen, Robert ;
Worrell, Gregory ;
Murro, Anthony M. ;
Edwards, Jonathan ;
Duchowny, Michael ;
Spencer, David ;
Smith, Michael ;
Geller, Eric ;
Gwinn, Ryder ;
Skidmore, Christopher ;
Eisenschenk, Stephan ;
Berg, Michel ;
Heck, Christianne ;
Van Ness, Paul ;
Fountain, Nathan ;
Rutecki, Paul ;
Massey, Andrew ;
O'Donovan, Cormac ;
Labar, Douglas ;
Duckrow, Robert B. ;
Hirsch, Lawrence J. ;
Courtney, Tracy ;
Sun, Felice T. ;
Seale, Cairn G. .
NEUROLOGY, 2015, 84 (08) :810-817
[6]   SUDDEN UNEXPECTED DEATH IN EPILEPSY - A SERIES FROM AN EPILEPSY SURGERY PROGRAM AND SPECULATION ON THE RELATIONSHIP TO SUDDEN CARDIAC DEATH [J].
DASHEIFF, RM .
JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 1991, 8 (02) :216-222
[7]   Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures [J].
DeGiorgio, CM ;
Schachter, SC ;
Handforth, A ;
Salinsky, M ;
Thompson, J ;
Uthman, B ;
Reed, R ;
Collins, S ;
Tecoma, E ;
Morris, GL ;
Vaughn, B ;
Naritoku, DK ;
Henry, T ;
Labar, D ;
Gilmartin, R ;
Labiner, D ;
Osorio, I ;
Ristanovic, R ;
Jones, J ;
Murphy, J ;
Ney, G ;
Wheless, J ;
Lewis, P ;
Heck, C .
EPILEPSIA, 2000, 41 (09) :1195-1200
[8]   Quantitative electrocorticographic biomarkers of clinical outcomes in mesial temporal lobe epileptic patients treated with the RNS® system [J].
Desai, Sharanya Arcot ;
Tcheng, Thomas K. ;
Morrell, Martha J. .
CLINICAL NEUROPHYSIOLOGY, 2019, 130 (08) :1364-1374
[9]   DEVELOPMENT OF THE QUALITY-OF-LIFE IN EPILEPSY INVENTORY [J].
DEVINSKY, O ;
VICKREY, BG ;
CRAMER, J ;
PERRINE, K ;
HERMANN, B ;
MEADOR, K ;
HAYS, RD .
EPILEPSIA, 1995, 36 (11) :1089-1104
[10]   Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation [J].
Devinsky, Orrin ;
Friedman, Daniel ;
Duckrow, Robert B. ;
Fountain, Nathan B. ;
Gwinn, Ryder P. ;
Leiphart, James W. ;
Murro, Anthony M. ;
Van Ness, Paul C. .
EPILEPSIA, 2018, 59 (03) :555-561